706 related articles for article (PubMed ID: 478014)
1. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
2. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
[TBL] [Abstract][Full Text] [Related]
3. The auto-antigen repertoire in myasthenia gravis.
Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
[TBL] [Abstract][Full Text] [Related]
4. Neonatal myasthenia gravis in the infant of a myasthenic mother in remission.
Elias SB; Butler I; Appel SH
Ann Neurol; 1979 Jul; 6(1):72-5. PubMed ID: 574370
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
6. Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction?
Sterz RK; Biro G; Rajki K; Filipp G; Peper K
J Immunol; 1985 Feb; 134(2):841-6. PubMed ID: 2578165
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
[No Abstract] [Full Text] [Related]
8. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
9. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
Gomez CM; Richman DP
J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
[TBL] [Abstract][Full Text] [Related]
10. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
Krolick KA; Yeh TM; Edlund SA
Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of myasthenia gravis.
Fulpius BW
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
13. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and pathophysiology of myasthenia gravis--role of anti-acetylcholine receptor antibody (author's transl)].
Nishitani H; Noguchi S; Ohta K; Matsubara S
No To Shinkei; 1980 Sep; 32(9):879-90. PubMed ID: 7437163
[No Abstract] [Full Text] [Related]
15. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
Denizot M; Fulpius BW; Cox JN; Ferrier PE
Helv Paediatr Acta; 1979 Sep; 34(4):375-80. PubMed ID: 521303
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
Simpson JA
Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
[TBL] [Abstract][Full Text] [Related]
18. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
19. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
20. Unravelling the pathogenesis of myasthenia gravis.
Vincent A
Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
